Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00681044 · FLOW

Participant flow

HD Melphalan and SCT in Patients With IGDD or LCDD · Source last updated 2017-04-28

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

groups
  1. description
    Mobilization with Filgrastim Stem Cell collection (SCC) Melphalan Conditioning Stem Cell infusion filgrastim: 16 mcg/kg daily beginning 3 days prior to SCC through day before final SCC melphalan: 70-100 mg/m2/day will be administered intravenously on Days -3 and -2 Stem Cell Infusion: infusion of previously collected stem cells on Day 0
    id
    FG000
    title
    SCT With Melphalan Conditioning
periods
  1. milestones
    1. achievements
      1. group Id
        FG000
        num Subjects
        4
      type
      STARTED
    2. achievements
      1. group Id
        FG000
        num Subjects
        4
      type
      COMPLETED
    3. achievements
      1. group Id
        FG000
        num Subjects
        0
      type
      NOT COMPLETED
    title
    Overall Study
pre Assignment Details
A patient enrolled on this study but was withdrawn due to insufficient stem cell yield. His clinical situation changed 5 months later and the investigators believed he would have a better yield so he was enrolled for a second time. Therefore, there were 5 enrollments, but 4 patients.
recruitment Details
Patients were enrolled from the Boston Medical Center Stem Cell Transplant Program between 2006 and 2009.
Complete source fields
groups
  1. description
    Mobilization with Filgrastim Stem Cell collection (SCC) Melphalan Conditioning Stem Cell infusion filgrastim: 16 mcg/kg daily beginning 3 days prior to SCC through day before final SCC melphalan: 70-100 mg/m2/day will be administered intravenously on Days -3 and -2 Stem Cell Infusion: infusion of previously collected stem cells on Day 0
    id
    FG000
    title
    SCT With Melphalan Conditioning
periods
  1. milestones
    1. achievements
      1. group Id
        FG000
        num Subjects
        4
      type
      STARTED
    2. achievements
      1. group Id
        FG000
        num Subjects
        4
      type
      COMPLETED
    3. achievements
      1. group Id
        FG000
        num Subjects
        0
      type
      NOT COMPLETED
    title
    Overall Study
pre Assignment Details
A patient enrolled on this study but was withdrawn due to insufficient stem cell yield. His clinical situation changed 5 months later and the investigators believed he would have a better yield so he was enrolled for a second time. Therefore, there were 5 enrollments, but 4 patients.
recruitment Details
Patients were enrolled from the Boston Medical Center Stem Cell Transplant Program between 2006 and 2009.

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice